172 results
Page 5 of 9
8-K
EX-10.1
eys1ktjvu q8x
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
8-K
2nru8yz8r63
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
gs7hazj
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-1.1
ofsmmn1bimb2o uxvt6
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
8-K
EX-5.1
ajlgy4jyo2sns
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
sj1oak
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
6udb531facjt
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.2
aquinm5xfsp1l
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.1
yi8 udkfsy3c20l
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
S-8
EX-5.1
bkjvv
30 Aug 19
Registration of securities for employees
12:30pm
S-8
o1offt2
30 Aug 19
Registration of securities for employees
12:30pm
8-K
EX-10.1
6zyql
27 Aug 19
Entry into a Material Definitive Agreement
8:39am